U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07730840) titled 'Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke' on July 23.
Brief Summary: The goal of this clinical trial is to learn if zastaprazan can help prevent upper gastrointestinal bleeding in adults who have recently had a transient ischemic attack (TIA) or ischemic stroke and are taking antiplatelet or anticoagulant medications. The main question it aims to answer is:
- Does zastaprazan reduce the risk of upper gastrointestinal bleeding compared to placebo in these patients?
Researchers will compare zastaprazan to a placebo (a look-alike tablet that contains no drug) to see if zastaprazan works to prevent upper ...